By analyzing the CSF signatures of the NTK markers in participants with a MoCA score <26 compared to cognitively unimpaired subjects, we found significantly increased CSF biomarker levels GFAP, NfL, S100, sTREM2, and YKL40 in the PD-MCI group. This evidence concerns the gene GFAP and Parkinson disease.